-+ 0.00%
-+ 0.00%
-+ 0.00%

Sarepta Therapeutics shareholders approve 2026 equity incentive plan at annual meeting

PUBT·06/04/2026 20:31:17
Listen to the news
Sarepta Therapeutics shareholders approve 2026 equity incentive plan at annual meeting
  • Sarepta Therapeutics held its annual shareholder meeting on June 4, 2026.
  • Shareholders adopted a 2026 Equity Incentive Plan, replacing the 2018 plan; up to 6,286,841 shares may be issued under awards.
  • Shareholders adopted a 2026 Employee Stock Purchase Plan, replacing the 2013 plan; 1,500,000 shares will be available for issuance.
  • KPMG was ratified as independent registered public accounting firm for the year ending Dec. 31, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sarepta Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-257501), on June 04, 2026, and is solely responsible for the information contained therein.